TY - JOUR
T1 - Spontaneous regression of optic gliomas
T2 - Thirteen cases documented by serial neuroimaging
AU - Parsa, Cameron F.
AU - Hoyt, Creig S.
AU - Lesser, Robert L.
AU - Weinstein, Joel M.
AU - Strother, Charles M.
AU - Muci-Mendoza, Rafael
AU - Ramella, Marcos
AU - Manor, Riri S.
AU - Fletcher, William A.
AU - Repka, Michael X.
AU - Garrity, James A.
AU - Ebner, Roberto N.
AU - Monteiro, Mario L.R.
AU - McFadzean, Robert M.
AU - Rubtsova, Irina V.
AU - Hoyt, William F.
PY - 2001
Y1 - 2001
N2 - Objective: To demonstrate spontaneous regression of large, clinically symptomatic optic pathway gliomas in patients with and without neurofibromatosis type 1 (NF-1). Methods: Patient cases were collected through surveys at 2 consecutive annual meetings of the North American Neuro-Ophthalmology Society (NANOS) and through requests on the NANOSNET Internet listserv. Serial documentation of tumor signal and size, using magnetic resonance imaging in 11 patients and computed tomography in 2 patients, was used to evaluate clinically symptomatic optic pathway gliomas. All tumors met radiologic criteria for the diagnosis ofglioma and 4 patients had biopsy confirmation of their tumors. In 3 patients, some attempt at therapy had been made many years before regression occurred. In one of these, radiation treatment had been given 19 years before tumor regression, while in another, chemotherapy had been administered 5 years before signal changes in the tumor. In the third patient, minimal surgical debulking was performed 1 year before the tumor began to shrink. Results: Spontaneous tumor shrinkage was noted in 12 patients. Eight patients did not have NF-1. In an additional patient without NF-1, a signal change within the tumor without associated shrinkage was detected. Tumor regression was associated with improvement in visual function in 10 of 13 patients, stability of function in 1, and deterioration in 2. Conclusions: Large, clinically symptomatic optic gliomas may undergo spontaneous regression. Regression was seen in patients with and without NF-1. Regression may manifest either as an overall shrinkage in tumor size, or as a signal change on magnetic resonance imaging. A variable degree of improvement in visual function may accompany regression. The possibility of spontaneous regression of an optic glioma should be considered in the planning of treatment of patients with these tumors.
AB - Objective: To demonstrate spontaneous regression of large, clinically symptomatic optic pathway gliomas in patients with and without neurofibromatosis type 1 (NF-1). Methods: Patient cases were collected through surveys at 2 consecutive annual meetings of the North American Neuro-Ophthalmology Society (NANOS) and through requests on the NANOSNET Internet listserv. Serial documentation of tumor signal and size, using magnetic resonance imaging in 11 patients and computed tomography in 2 patients, was used to evaluate clinically symptomatic optic pathway gliomas. All tumors met radiologic criteria for the diagnosis ofglioma and 4 patients had biopsy confirmation of their tumors. In 3 patients, some attempt at therapy had been made many years before regression occurred. In one of these, radiation treatment had been given 19 years before tumor regression, while in another, chemotherapy had been administered 5 years before signal changes in the tumor. In the third patient, minimal surgical debulking was performed 1 year before the tumor began to shrink. Results: Spontaneous tumor shrinkage was noted in 12 patients. Eight patients did not have NF-1. In an additional patient without NF-1, a signal change within the tumor without associated shrinkage was detected. Tumor regression was associated with improvement in visual function in 10 of 13 patients, stability of function in 1, and deterioration in 2. Conclusions: Large, clinically symptomatic optic gliomas may undergo spontaneous regression. Regression was seen in patients with and without NF-1. Regression may manifest either as an overall shrinkage in tumor size, or as a signal change on magnetic resonance imaging. A variable degree of improvement in visual function may accompany regression. The possibility of spontaneous regression of an optic glioma should be considered in the planning of treatment of patients with these tumors.
UR - http://www.scopus.com/inward/record.url?scp=0035070021&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0035070021&partnerID=8YFLogxK
U2 - 10.1001/archopht.119.4.516
DO - 10.1001/archopht.119.4.516
M3 - Article
C2 - 11296017
AN - SCOPUS:0035070021
SN - 0003-9950
VL - 119
SP - 516
EP - 529
JO - Archives of ophthalmology
JF - Archives of ophthalmology
IS - 4
ER -